Ana Valdehíta - Concepedia

Author

Ana Valdehíta

Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria ORCID

Also Known As

A. Valdehita, A. Valdehíta, Ana Valdehita, Ana Valdehíta

Publications

700

Citations

H-Index

Concepts

All Affiliations

Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria Universidad de Alcalá Consejo Superior de Investigaciones Científicas Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas Hospital Universitario Príncipe de Asturias

About

Ana Valdehíta is an author at Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria specializing in medicine, toxicology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	471
2	Engineering	4	4	97
3	Education	2	2	34
4	Health Sciences	1	1	26
5	Natural Sciences	1	1	27

Ana Valdehíta

Publications

639

Citations

H-Index

Page 1

	Year	Citations
Effects of aflatoxin B1, fumonisin B1 and their mixture on the aryl hydrocarbon receptor and cytochrome P450 1A induction Verónica S. Mary, Ana Valdehíta, José M. Navas, Food and Chemical Toxicology BiochemistryAflatoxin B1MedicineAryl Hydrocarbon ReceptorFumonisin B1	2014	65
Vasoactive intestinal peptide (VIP) induces transactivation of EGFR and HER2 in human breast cancer cells Ana Valdehíta, Ana M. Bajo, Andrew V. Schally, Molecular and Cellular Endocrinology ImmunologyBreast CancerVasoactive Intestinal PeptideMedicineCell Biology	2008	56
Determining the presence of chemicals with suspected endocrine activity in drinking water from the Madrid region (Spain) and assessment of their estrogenic, androgenic and thyroidal activities Yolanda Valcárcel, Ana Valdehíta, Eva María Fagundo Becerra, Chemosphere Drinking WaterEndocrine DisruptorsEndocrine MechanismMadrid RegionMedicine	2018	54
Nuclear localization of vasoactive intestinal peptide (VIP) receptors in human breast cancer Ana Valdehíta, Ana M. Bajo, Ana B. Fernández‐Martínez, Peptides Gastrointestinal Peptide HormoneSignal TransductionReceptor (Biochemistry)Neuropeptide ReceptorHuman Breast Cancer	2010	53
Endocrine disruption caused by oral administration of atrazine in European quail (Coturnix coturnix coturnix) Irene de la Casa‐Resino, Ana Valdehíta, Francisco Soler Rodríguez, Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology Animal PhysiologyEndocrine DisruptorsCaprineAnimal ScienceMedicine	2012	43
Thyroid signaling in immune organs and cells of the teleost fish rainbow trout (Oncorhynchus mykiss) Alba Quesada-García, Ana Valdehíta, Christian Kropf, Fish & Shellfish Immunology BiologyOncorhynchus MykissImmunologyFish ImmunologyThyroid Hormone	2014	42
Vasoactive intestinal peptide (VIP) increases vascular endothelial growth factor (VEGF) expression and secretion in human breast cancer cells Ana Valdehíta, Marı́a J. Carmena, Beatriz Collado, Regulatory Peptides Tumor BiologyGastrointestinal Peptide HormoneAngiogenesisImmunologyEndothelial Dysfunction	2007	34
Ecotoxicological assessment of soils polluted with chemical waste from lindane production: Use of bacterial communities and earthworms as bioremediation tools Selene Muñiz, Pilar Gonzalvo, Ana Valdehíta, Ecotoxicology and Environmental Safety EngineeringEnvironmental EngineeringBioremediation ToolsLindane ProductionBioremediation	2017	30
RNA interference-directed silencing of VPAC1 receptor inhibits VIP effects on both EGFR and HER2 transactivation and VEGF secretion in human breast cancer cells Ana Valdehíta, Marı́a J. Carmena, Ana M. Bajo, Molecular and Cellular Endocrinology Her2 TransactivationBreast OncologyMedicineVegf SecretionBreast Cancer	2011	29
Biological and chemical studies on aryl hydrocarbon receptor induction by the p53 inhibitor pifithrin-α and its condensation product pifithrin-β María Luisa Fernández‐Cruz, Ana Valdehíta, Mercedes Alonso, Life Sciences Molecular PharmacologyMedicinal ChemistryChemical StudiesBiochemistryMedicine	2011	27

Page 1